UTHealth stroke researchers on the leading edge of stem cell science

The effects of multipotent adult progenitor stem cells on stroke recovery were the focus of two recently published papers that include researchers at the Institute for Stroke and Cerebrovascular Disease at The University of Texas Health Science Center at Houston (UTHealth).

Results of a pre-clinical study led by UTHealth researchers that examined the effects of MultiStem®, a human bone marrow stem cell product, were published in a recent issue of the journal Stem Cells. Results of a phase 2 clinical trial of MultiStem®, which included McGovern Medical School researchers, were published today in the journal Lancet Neurology.

Read Article on UT Health Website